Prospective observation study of patients with Chorioretinopathia centralis serous to identify hormonal and metabolic risk factors for chronification

Prospective observation study of patients with Chorioretinopathia centralis serous to identify hormonal and metabolic risk factors for chronification - STARS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00013310

Enrollment

100

Registered

2018-02-21

Start date

2018-01-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H35.7

Interventions

Group 1: Patients with CRCS, observation study with 3 visits (baseline, 2 months, 1 year) with questionnaire, retinal imaging and blood collection

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Informed consent Acute onset of clinical complaints in the last three weeks Clinical diagnosis of CSC using retinal imaging

Exclusion criteria

Exclusion criteria: Lack of informed consent for the clinical trial Presence of accompanying retinal diseases (e.g. high myopia >-8dpt, age-related macular degeneration, diabetic macular edema, macular dystrophy) Unter 18 years old

Design outcomes

Primary

Measure	Time frame
Identification of chronification (defined as persistence of the disease) of acutely occurring CRCS cases within 2 months	—

Secondary

Measure	Time frame
Long-term observation of 1 years, identification of risk factors on the basis of questionnaires, retinal imaging, metabolic and hormonal risk factors	—

Countries

Germany

Contacts

Public ContactVasilena Sitnilska

Zentrum für Augenheilkunde, Uniklinik Köln

vasilena.sitnilska@uk-koeln.de+49 221 478 4313

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026